PROSOMNUS INC(NASDAQ:OSA) stock News

OSA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: BusinessInsider

OSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023

2 years ago - By: InvestorPlace

OSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023

2 years ago - By: Benzinga - Mentions: IRIX UTHR TTNP CARA ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

2 years ago - By: Benzinga

Roth MKM Maintains Buy Rating for ProSomnus: Here's What You Need To Know

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea

2 years ago - By: ProSomnus Sleep Technologies, Inc.

Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices

2 years ago - By: InvestorPlace - Mentions: ADTX CNXA AMPE CMND ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Announces Third Quarter 2023 Investor Call and Business Update

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Announces Third Quarter 2023 Investor Call and Business Update

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference

2 years ago - By: Seeking Alpha

ProSomnus closes $10M preferred equity round (NASDAQ:OSA)

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences

2 years ago - By: ProSomnus Sleep Technologies, Inc.

ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences

2 years ago - By: ProSomnus Sleep Technologies, Inc.

Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea

PROSOMNUS INC (OSA) Stock News

OSA Latest News, Press Relases and Analysis